Frequent use of blood-saving measures in elective orthopaedic surgery: A 2012 Dutch blood management survey

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Voorn, Veronique M A ^a   Marang Van De Mheen, Perla J ^a   Wentink, Manon M ^a   So Osman, Cynthia ^b   Vliet Vlieland, Thea P M ^a   Koopman Van Gemert, Ankie W M M ^c   Nelissen, Rob G H H ^a   Van Bodegom Vos, Leti ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Arthroplasty; Blood management; Orthopedics; Survey

Indexed keywords

ANTITHROMBOCYTIC AGENT; ERYTHROPOIETIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ARTHROPLASTY; BLOOD SALVAGE; BLOOD SAVING MEASURE; BLOOD TRANSFUSION; BLOOD VOLUME; ELECTIVE SURGERY; GENERAL HOSPITAL; HEALTH CARE SURVEY; HEMATOLOGICAL PROCEDURE; HEMODILUTION; INTERNET; LIKERT SCALE; NETHERLANDS; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRIVATE HOSPITAL; QUESTIONNAIRE; REPEAT PROCEDURE; REVIEW; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

ARTHROPLASTY, REPLACEMENT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; DRAINAGE; HOSPITALS; HUMANS; INTERNET; ORTHOPEDICS; PLASMAPHERESIS; QUESTIONNAIRES; SURGICAL PROCEDURES, ELECTIVE;

EID: 84880987992     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-230     Document Type: Review

References (20)

1. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Spahn DR, Anesthesiology 2010 113 482 495 10.1097/ALN.0b013e3181e08e97 20613475
2. Risks of transfusion. Squires JE, South Med J 2011 104 762 769 10.1097/SMJ.0b013e31823213b6 22024787
3. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. Green WS, Toy P, Bozic KJ, J Arthroplasty 2010 25 93 96 10.1016/j.arth.2008.10.005 19056224
4. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Laupacis A, Fergusson D, Transfus Med 1998 8 309 317 10.1046/j.1365-3148.1998.00171.x 9881425 (Pubitemid 28552019)
5. Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Moonen AF, Neal TD, Pilot P, Injury 2006 37 11 S16 Suppl 5 17338906
6. A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty. Rao VK, Dyga R, Bartels C, Waters JH, Transfusion 2012 52 1750 1760 10.1111/j.1537-2995.2011.03531.x 22339139
7. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM, J Bone Joint Surg Br 2011 93 1577 1585 10.2106/JBJS.J.01048 22161917
8. Cell salvage for minimising perioperative allogeneic blood transfusion. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA, Cochrane Database Syst Rev 2010 4 D001888 20393932
9. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Cochrane Database Syst Rev 2011 3 D001886 21412876
10. Quality of assessment of randomized controlled trials in blood conservation after joint arthroplasty. Sharma R, Farrokhyar F, McKnight LL, Bhandari M, Poolman RW, Adili A, J Arthroplasty 2011 26 909 913 10.1016/j.arth.2010.08.014 21074359
11. Dutch Institute for Healthcare Improvement (CBO), Guideline Bloodtransfusionpolicy (in Dutch) 2011 Available at: http://www.cbo.nl
12. A randomised controlled trial on erythropoietin and blood salvage as transfusion alternatives in orthopaedic surgery using restrictive transfusion policy. So-Osman C, Nelissen RGHH, Koopman-van Gemert AWMM, Kluyver E, Pöll R, Onstenk R, Patient Blood Management in Elective Orthopaedic Surgery 2012 ISBN 9789461914569
13. 2007-2011 data on the Dutch Arthroplasty Register (LROI) 2013 http://www.lroi.nl 2007
14. Designing a strategy to implement cost-effective blood transfusion management in elective hip and knee arthroplasties: A study protocol. Voorn VM, Marang-van de Mheen PJ, So-Osman C, Vliet Vlieland TP, Koopman-van Gemert AW, Nelissen RG, Implement Sci 2012 7 58 10.1186/1748-5908-7-58 22747693
15. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. Fergusson D, Blair A, Henry D, Hisashige A, Huet C, Koopman-van GA, et al. Int J Technol Assess Health Care 1999 15 717 728 10645113 (Pubitemid 30033518)
16. Dutch orthopedic blood management surveys 2002 and 2007: an increasing use of blood-saving measures. Horstmann WG, Ettema HB, Verheyen CC, Arch Orthop Trauma Surg 2010 130 55 59 10.1007/s00402-009-0910-0 19529950
17. Healthcare inspection, Transparent Care (in Dutch) 2012 Available at http://www.zichtbarezorg.nl
18. Evaluating comorbidities in total hip and knee arthroplasty: available instruments. Bjorgul K, Novicoff WM, Saleh KJ, J Orthop Traumatol 2010 11 203 209 10.1007/s10195-010-0115-x 21076850
19. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Slappendel R, Dirksen R, Weber EW, Van der Schaaf DB, Acta Orthop Scand 2003 74 569 575 10.1080/00016470310017974 14620978 (Pubitemid 37310964)
20. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A, Vox Sang 2010 98 56 64 10.1111/j.1423-0410. 2009.01225.x 19656349